Monday, May 29, 2017
Company News: Page (1) of 1 - 05/19/17 Email this story to a friend. email article Print this page (Article printing at page facebook
Global Ulcerative Colitis Market and Forecast Analysis Report 2015-2035 - Research and Markets
(May 19, 2017)

DUBLIN, May 19, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Ulcerative Colitis Market and Forecast Analysis" report to their offering.

Research and Markets Logo

Ulcerative colitis is a chronic inflammatory bowel disease that is characterized by inappropriate diffuse inflammation of the rectal and colonic mucosa, which occurs in the innermost layer of the intestinal lining. Ulcerative colitis is a chronic, incurable disease with low mortality that is generally diagnosed in adolescence and early adulthood.

Ulcerative colitis is currently an idiopathic condition, the pathogenesis of which is yet to be fully elucidated. However, it is known to involve an interaction between genetics, the immune system, and environmental factors. Risk factors include ethnicity, family history, antibiotic or non-steroidal anti-inflammatory agent use, and diet. Incidence and prevalence have been increasing over the past two decades in most regions of the world.

It is estimated that in 2015, there were 2.1 million diagnosed prevalent cases of ulcerative colitis in the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK). Over 2015-35, the number of prevalent cases is expected to increase to 2.5 million (16.6% increase).

Key Topics Covered:

1. Treatment: Ulcerative Colitis

  • Patient Segmentation
  • Country Treatment Trees: Crohn's Disease
  • Country Treatment Trees: Ulcerative Colitis
  • Current Treatment Options
  • Prescribing Trends: Crohn's Disease
  • Prescribing Trends: Ulcerative Colitis
  • Prescribing Influences
  • Unmet Needs in Inflammatory Bowel Disease

2. Epidemiology: Ulcerative Colitis

  • Disease Background
  • Sources and Methodology
  • Forecast
  • Epidemiologist Insight
  • Strengths and Limitations

3. Marketed Drugs: Ulcerative Colitis

  • Product profile: Apriso
  • Product profile: Delzicol/Asacol HD
  • Product profile: Entyvio
  • Product profile: Humira
  • Product profile: Lialda
  • Product profile: Pentasa
  • Product profile: Remicade
  • Product profile: Simponi
  • Product profile: Uceris

4. Pipeline: Ulcerative Colitis

  • Clinical Pipeline Overview
  • Target Product Profile
  • Product profile (late stage): LT-02
  • Product profile (late stage): Xeljanz
  • Product profile (late stage): etrolizumab

5. Appendix

  • Appendix: Marketed Drugs: Ulcerative Colitis
  • Appendix: Pipeline: Ulcerative Colitis

For more information about this report visit

Media Contact:

Laura Wood, Senior Manager 

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


To view the original version on PR Newswire, visit:

SOURCE Research and Markets

Copyright 2014 PR Newswire. All Rights Reserved

Page: 1

Related Keywords:Diet, Disease, Surgery, Science, Medical, Biology, Genetics, Family,
Related Sites: HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • Silver Birch of Hammond Affordable Assisted Lifestyle Community Opens Doors
  • Male Infertility Market Size Worth $4.7 Billion by 2025 | CAGR: 4.6%: Grand View Research, Inc.
  • Dental Radiology and Dental Imaging Devices market is expected to grow with CAGR of approximately 10%
  • NetDirector Enables Next-Generation Integration in Radiology with American Health Imaging
  • APR Applied Pharma Research at the 9th ChinaBio® Partnering Forum: Bringing Swiss Made Innovations and Science Driven Technologies to Strengthen Its Presence in the Chinese Market

  • Cone beam computed tomography (CBCT) Systems Market Expected to Reach $1,041 Million, Globally, by 2023 - Allied Market Research
  • Mesothelioma Compensation Center Now Urges the Family of a Person Who Recently Died From Mesothelioma Before They Could Hire a Lawyer to File a Claim to Call for Instant Help
  • Mapi Research Trust Unveils New Clinical Outcome Assessments (COA) Website for the Zarit Burden Interview (ZBI) Questionnaire
  • Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2010 - 2017: Deal trends, players, financials and forecasts
  • Artificial Intelligence Firm Set to Revolutionize Healthcare

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines